Загрузка...
The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease
Immune checkpoint inhibitor (ICI) is a revolutionary breakthrough in the field of cancer treatment. Because of dysregulated activation of the immune system, patients with autoimmune disease (AID) are usually excluded from ICI clinical trials. Due to a large number of cancer patients with preexisting...
Сохранить в:
| Опубликовано в: : | Front Oncol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7937882/ https://ncbi.nlm.nih.gov/pubmed/33692958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.625872 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|